MENU
+Compare
ANIP
Stock ticker: NASDAQ
AS OF
Jan 17 closing price
Price
$58.46
Change
+$0.96 (+1.67%)
Capitalization
1.43B

ANIP ANI Pharmaceuticals Forecast, Technical & Fundamental Analysis

a manufacturer of branded and generic prescription pharmaceuticals

ANIP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for ANIP with price predictions
Jan 14, 2025

ANIP sees its Stochastic Oscillator ascends from oversold territory

On December 27, 2024, the Stochastic Oscillator for ANIP moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 53 instances where the indicator left the oversold zone. In of the 53 cases the stock moved higher in the following days. This puts the odds of a move higher at over .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for ANIP just turned positive on January 02, 2025. Looking at past instances where ANIP's MACD turned positive, the stock continued to rise in of 60 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ANIP advanced for three days, in of 300 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on January 13, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on ANIP as a result. In of 95 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ANIP declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ANIP’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.305) is normal, around the industry mean (58.228). P/E Ratio (79.847) is within average values for comparable stocks, (89.834). ANIP's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.877). Dividend Yield (0.000) settles around the average of (0.120) among similar stocks. P/S Ratio (2.537) is also within normal values, averaging (19.449).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ANIP’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock worse than average.

View a ticker or compare two or three
ANIP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

ANIP is expected to report earnings to rise 8.21% to $1.45 per share on February 27

ANI Pharmaceuticals ANIP Stock Earnings Reports
Q4'24
Est.
$1.45
Q3'24
Beat
by $0.26
Q2'24
Beat
by $0.07
Q1'24
Beat
by $0.23
Q4'23
Beat
by $0.14
The last earnings report on November 08 showed earnings per share of $1.34, beating the estimate of $1.08. With 302.52K shares outstanding, the current market capitalization sits at 1.43B.
A.I. Advisor
published General Information

General Information

a manufacturer of branded and generic prescription pharmaceuticals

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
210 Main Street West
Phone
+1 218 634-3500
Employees
642
Web
https://www.anipharmaceuticals.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
BTC.X104462.0400004705.133000
+4.72%
Bitcoin cryptocurrency
TSLA426.5012.68
+3.06%
Tesla
SPY597.585.94
+1.00%
SPDR® S&P 500® ETF Trust
AAPL229.981.72
+0.75%
Apple
GME27.51-0.21
-0.76%
GameStop Corp

ANIP and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ANIP has been loosely correlated with DRRX. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if ANIP jumps, then DRRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANIP
1D Price
Change %
ANIP100%
+1.67%
DRRX - ANIP
38%
Loosely correlated
+2.15%
PAHC - ANIP
30%
Poorly correlated
-0.53%
ORGO - ANIP
26%
Poorly correlated
+0.30%
PBH - ANIP
25%
Poorly correlated
+0.38%
AMRX - ANIP
24%
Poorly correlated
-0.60%
More